Scott D Rogers
Overview
Explore the profile of Scott D Rogers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shams-White M, Barajas R, Jensen R, Rotunno M, Dueck H, Ginexi E, et al.
PLoS One
. 2021 Apr;
16(4):e0250061.
PMID: 33857240
Objectives: Systems epidemiology approaches may lead to a better understanding of the complex and dynamic multi-level constellation of contributors to cancer risk and outcomes and help target interventions. This grant...
2.
Kennedy A, Khoury M, Ioannidis J, Brotzman M, Miller A, Lane C, et al.
Cancer Epidemiol Biomarkers Prev
. 2016 Jul;
25(10):1392-1401.
PMID: 27439404
Background: We report on the establishment of a web-based Cancer Epidemiology Descriptive Cohort Database (CEDCD). The CEDCD's goals are to enhance awareness of resources, facilitate interdisciplinary research collaborations, and support...
3.
Lam T, Chang C, Rogers S, Khoury M, Schully S
Am J Epidemiol
. 2015 Mar;
181(7):451-8.
PMID: 25767265
Concurrently with a workshop sponsored by the National Cancer Institute, we identified key "drivers" for accelerating cancer epidemiology across the translational research continuum in the 21st century: emerging technologies, a...
4.
Lam T, Chang C, Rogers S, Khoury M, Schully S
Am J Epidemiol
. 2015 Mar;
181(7):463.
PMID: 25767264
No abstract available.
5.
Schully S, Rogers S, Lam T, Chang C, Clyne M, Cyr J, et al.
Cancer Epidemiol Biomarkers Prev
. 2014 Nov;
23(11):2610-1.
PMID: 25368405
No abstract available.
6.
Carrick D, Mette E, Hoyle B, Rogers S, Gillanders E, Schully S, et al.
Biopreserv Biobank
. 2014 Aug;
12(4):240-5.
PMID: 25162460
Over the past two decades, researchers have increasingly used human biospecimens to evaluate hypotheses related to disease risk, outcomes and treatment. We conducted an analysis of population-science cancer research grants...
7.
Lam T, Schully S, Rogers S, Benkeser R, Reid B, Khoury M
Cancer Epidemiol Biomarkers Prev
. 2013 Feb;
22(4):496-500.
PMID: 23413299
In a time of scientific and technological developments and budgetary constraints, the National Cancer Institute's (NCI) Provocative Questions Project offers a novel funding mechanism for cancer epidemiologists. We reviewed the...
8.
Allen J, Mantyh P, Horais K, Tozier N, Rogers S, Ghilardi J, et al.
Toxicol Sci
. 2006 Feb;
91(1):286-98.
PMID: 16500924
Intrathecal (IT) substance P-Saporin (SP-SAP), a 33-kDa-targeted neurotoxin, produces selective destruction of superficial neurokinin 1 receptor (NK1r)-bearing cells in the spinal dorsal horn. In rats, SP-SAP prevents the formation of...
9.
Burchard E, Borrell L, Choudhry S, Naqvi M, Tsai H, Rodriguez-Santana J, et al.
Am J Public Health
. 2005 Nov;
95(12):2161-8.
PMID: 16257940
Latinos are the largest minority population in the United States. Although usually classified as a single ethnic group by researchers, Latinos are heterogeneous from cultural, socioeconomic, and genetic perspectives. From...
10.
Ghilardi J, Svensson C, Rogers S, Yaksh T, Mantyh P
J Neurosci
. 2004 Mar;
24(11):2727-32.
PMID: 15028765
Inhibitors of the isozyme cyclooxygenase-2 (COX-2) represent an important advance in pain management, although where and when these inhibitors can exert their antihyperalgesic actions are not completely understood. Here we...